4.6 Article

Inhibiting amyloid beta (1-42) peptide-induced mitochondrial dysfunction prevents the degradation of synaptic proteins in the entorhinal cortex

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis

Theophania Ashleigh et al.

Summary: Mitochondrial dysfunction plays a central role in the pathogenesis of Alzheimer's disease, challenging the conventional thinking of amyloid beta pathology. A unified model that accurately identifies the underlying mechanism of AD is crucial for the development of effective therapies.

ALZHEIMERS & DEMENTIA (2023)

Review Biology

Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease

Olayemi Joseph Olajide et al.

Summary: The entorhinal cortex plays a crucial role in the early development of Alzheimer's disease, with degenerative changes impacting memory and cognitive function, signaling pathways involving oxidative stress, neuroinflammation, and neuronal loss are key factors in the pathogenesis.

BIOLOGY OPEN (2021)

Review Endocrinology & Metabolism

Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective

Patrycja Mulica et al.

Summary: Declining brain energetics play a role in aging and neurodegenerative diseases like Alzheimer's and Parkinson's. Recent evidence suggests that astrocytes, key in supporting neuronal function, may also contribute to the development of these diseases. Understanding the metabolic interactions between astrocytes and neurons, particularly regarding mitochondria, has therapeutic potential in addressing neurodegenerative disorders.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Biochemistry & Molecular Biology

The Amyloid-β Pathway in Alzheimer's Disease

Harald Hampel et al.

Summary: Breakthroughs in molecular medicine have highlighted the significance of the amyloid-beta pathway in the pathophysiology of Alzheimer's disease. Established biochemical alterations of the A beta cycle serve as promising targets for the development of disease-modifying therapies. Research indicates a crucial role of A beta pathway dyshomeostasis in the dynamics of AD pathophysiology, supporting the development of A beta-targeting therapeutic strategies for early treatment of AD.

MOLECULAR PSYCHIATRY (2021)

Review Biochemistry & Molecular Biology

The MICOS complex, a structural element of mitochondria with versatile functions

Siavash Khosravi et al.

BIOLOGICAL CHEMISTRY (2020)

Review Clinical Neurology

New Insights Into the Pathogenesis of Alzheimer's Disease

Liyuan Fan et al.

FRONTIERS IN NEUROLOGY (2020)

Review Neurosciences

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

Tiantian Guo et al.

MOLECULAR NEURODEGENERATION (2020)

Article Environmental Sciences

Reversal of behavioral decline and neuropathology by a complex vitamin supplement involves modulation of key neurochemical stressors

Olayemi Joseph Olajide et al.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2018)

Article Clinical Neurology

Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease

Eleanor K. Pickett et al.

ACTA NEUROPATHOLOGICA (2018)

Article Neurosciences

Identification of CHCHD10 Mutation in Chinese Patients with Alzheimer Disease

Tingting Xiao et al.

MOLECULAR NEUROBIOLOGY (2017)

Article Environmental Sciences

Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer's disease

Olayemi Joseph Olajide et al.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2017)

Review Neurosciences

Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease

Eric Tonnies et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Endocrinology & Metabolism

Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats

Olayemi Joseph Olajide et al.

METABOLIC BRAIN DISEASE (2017)

Article Medicine, Research & Experimental

Mitochondrial cytochrome c oxidase deficiency

Malgorzata Rak et al.

CLINICAL SCIENCE (2016)

Article Neurosciences

Entorhinal cortex: a good biomarker of mild cognitive impairment and mild Alzheimer's disease

Mengxi Zhou et al.

REVIEWS IN THE NEUROSCIENCES (2016)

Review Pharmacology & Pharmacy

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Cassia R. Overk et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Review Biochemistry & Molecular Biology

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

Xinglong Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Biophysics

Beta-Amyloid Oligomers Activate Apoptotic BAK Pore for Cytochrome c Release

Jaewook Kim et al.

BIOPHYSICAL JOURNAL (2014)

Review Neurosciences

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease

Shichun Tu et al.

MOLECULAR NEURODEGENERATION (2014)

Article Pharmacology & Pharmacy

Key Role of Mitochondria in Alzheimer's Disease Synaptic Dysfunction

Virve Cavallucci et al.

CURRENT PHARMACEUTICAL DESIGN (2013)

Article Neurosciences

Entorhinal Cortex Thickness Predicts Cognitive Decline in Alzheimer's Disease

Latha Velayudhan et al.

JOURNAL OF ALZHEIMERS DISEASE (2013)

Article Medicine, Research & Experimental

Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction

Lennart Mucke et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Medicine, Research & Experimental

Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease

Colin L. Masters et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Review Behavioral Sciences

The cholinergic system in aging and neuronal degeneration

Reinhard Schliebs et al.

BEHAVIOURAL BRAIN RESEARCH (2011)

Article Neurosciences

Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration

David A. Patten et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Review Neurosciences

Oxidative stress in Alzheimer disease: A possibility for prevention

David J. Bonda et al.

NEUROPHARMACOLOGY (2010)

Review Geriatrics & Gerontology

Selective neuronal vulnerability to oxidative stress in the brain

Xinkun Wang et al.

FRONTIERS IN AGING NEUROSCIENCE (2010)

Review Clinical Neurology

Synaptic degeneration in Alzheimer's disease

Thomas Arendt

ACTA NEUROPATHOLOGICA (2009)

Review Biochemistry & Molecular Biology

How mitochondria produce reactive oxygen species

Michael P. Murphy

BIOCHEMICAL JOURNAL (2009)

Review Neurosciences

Alzheimer's disease: synaptic dysfunction and Aβ

Ganesh M. Shankar et al.

MOLECULAR NEURODEGENERATION (2009)

Review Biochemistry & Molecular Biology

Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease

Magdolna Paskaski et al.

NEUROCHEMISTRY INTERNATIONAL (2008)

Review Cell Biology

Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide

Christian Haass et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Seeding specificity in amyloid growth induced by heterologous fibrils

B O'Nuallain et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Clinical Neurology

Higher atrophy rate of entorhinal cortex than hippocampus in AD

AT Du et al.

NEUROLOGY (2004)

Article Geriatrics & Gerontology

Synaptic slaughter in Alzheimer's disease

PD Coleman et al.

NEUROBIOLOGY OF AGING (2003)

Article Biochemistry & Molecular Biology

In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis

WB Stine et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Multidisciplinary Sciences

Alzheimer's disease is a synaptic failure

DJ Selkoe

SCIENCE (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Reduction of vesicular acetylcholine transporter in β-amyloid protein-infused rats with memory impairment

E Ikeda et al.

NUCLEAR MEDICINE COMMUNICATIONS (2000)